May 1986, Volume 36, Issue 5

Original Article


Ashfaq Ahmad  ( Department of Paediatrics and Department of Pathology, Khyber Medical College, Peshawar. )
Amina Zohra  ( Department of Paediatrics and Department of Pathology, Khyber Medical College, Peshawar. )
Nighat Yasmin  ( Department of Paediatrics and Department of Pathology, Khyber Medical College, Peshawar. )


A new anthelmintic drug Alben­was dazole (Zentel) was tested for its efficacy and tolerance in 100 children having single or   mixed infestation  with roundworms, hookworms, whipworms, pinworms and tapeworms. Their stools were examined by direct examination and by centrifugal floatation technique. The patients were observed carefully before and after treat­ment, for clinical efficacy, side effects or any alterations in haematology, blood chemistry and urine.
After a single dose of Albendazole (400 mg) the cure rate was 100% in Ascariasis and Ancy­lostomiasis. When this drug was given in the same dosage for three consecutive days the cure rate was 100% in Taeniasis and 60.6% in Hymenolepis nana.
Albendazole was well tolerated and labor­atory investigations showed no significant bio­chemical abnormalities (JPMA 36: 114, 1986).


Helminthiasis is a common problem of the tropics and subtropical countries where health Care Programmes are still deficient. Contaminated drinking water, unhygenic living habits, poor sanitation, poverty, over-crowding and lack of health education are the main causes of different infections along with worm infestation.
Albendazole, a new benzimidazole derivative is methyl-5-prophylthio-1 -H benzimidazole-2-yl carbamate. The drug is a widely used broad-spectrum anthelmintjc in veterinary practice.1,2 Recently it has been studied for use in humans, and initial studies have found it to be highly effective against ancylostomiasis, ascariasis, enterobiasis, trichuriasis and taeniasis in a single dose of 400 mg. It hás also been found effective against Hymenolepis nana and Strongyloides stercoralis infestation when given in a dose of 400 mg for three consecutive days.3 Very few side effects have been noted so far..
Many studies4-10  have been carried out on the prevalence of intestinal parasitosis in Pakistan showing the highest incidence of Ascariasis followed by Ancylostomiasis and Taeniasis but to our knowledge very few have studied the effectiveness of drugs used in treating intestinal helminthiasis.
The present study was conducted in order to evaluate the efficacy and tolerance of Albendazole in children with intestinal helminthiasis.


Hundred children with positive stool examinations were included in the study. Most of them were indoor patients, though out-door patients who came with a history of passage or worms in stools or with complaints of pain in abdomen, distension, diarrhoea, nausea, wheezy chest, pallor or pruritus were included. Those who were seriously ill or had proteinuria, convulsive disorders, blood dyscrasias were included in the study. All patients gave their fully informed consent and were told of their right to withdraw from the study at any time.
Faecal examination was dpne by direct microscopy which consisted of two direct cover glass films placed on a slide side by side, one in physiological saline and the other examined with
D. Antonis Iodine. For staining cysts, a small amount of faeces was emulsified in a drop of D. Antonis iodine and was examined under the microscope immediately.’ Negative Samples were further checked by zinc sulphate centrifugal floatation technique. The concentration was effected by suspending portion of the faeces (about 0.5 gms) in approximately 8 ml of tap water contained in shell vial. After stoppering, the material was thoroughly mixed by shaking then strained through two thicknesses of damp gauze into a 12 by 100mm tube. ‘fliis suspension was centrifuged at 1800 rpm for 45 seconds and zinc sulfate solutions (sp. Gravity 1.180) was added to near the top of tube. Then re-suspension of the faecal material by agitation, sufficient amount of zinc sulfate solution was added to produce a convex meniscus. The tube was allowed to stand for 10 minutes after which a slide was touched to the top of the meniscus, then carefully inverted. The material thus obtained was stained with iodine and examined.
Before starting treatment with Albendazole, a complete physical examination full blood count, PCV, RBC, Serum Bilirubin, SGPT, Blood Urea and urine examination were carried out. Albendazole suspension 400 mg per 20 ml or
Albendazole tablet 200 mg were used.
Stools were re-examined on day 7, 14 and 21 and all the above mentioned investigations were repeated.


The ages ranged between 2-14 years. There were 65 males and 35 females.
Out of 100 patients 87% had a single infestation whereas 13% had mixed worm infestation.
Of 87 cases with single worm infestation 43% had Ascaris lumbricoides and 38% Hymeno­lepis nana (Table I).

Mixed infestation was present in 13 cases only.

Table II shows the types of helminths found in mixed infestation.
The efficacy of Albendazole was assessed on examination of post treatment faecal samples of stools on day 7, 14 and 21.
In 37 patients of Ascariasis 33 were cured by single dose of 400 mg and the rest became free of infection by a repeat dose of 400 mg. In 12 patients with ancylostoma duodenale infection cure rate was 100% with single dose of Albendazole. Same was with single infection of Trichuris trichiura and Entrobius vermicularis. 100% cure rate was seen in cases of Taenia saginata when Albendazole was given at the dose of 400 mg daily for 3 consecutive days. 33 patients with H. nana infection were given Albendazole 400 mg daily for 3 consecutive days and cure rate was 60.6% and it rose to 66.66% after a 2nd dose was given after three weeks (Table III).

In 13 cases of mixed infection, the drug cured 10 patients (76.9%) while in 3 patients one of the worms was seen in the stool samples collected 7-14 days after treatment. A second dose was given to them but all three children were lost to follow up (Table III).
Albendazole was well tolerated. No change in blood chemistry or haematological parameters were observed within seven days or after the completion of treatment (Table IV).

The initial Hb% in all the children was low most probably due to infection, worm infestation, and malnut­rition and same was the PVC and RBC count. There was no significant change in Hb, RBC or PVC after Albendazole therapy.
Side Effects
Four percent of the patients complained of nausea and 2% of pain in epigastrium while 6% said that they felt giddy for a few hours (Table V).


Worm infestation remains a major health hazard in the paediatric age group in Pakistan. Although no large scale surveys have been done to show the actual prevalence in the community, the few available studies4-10 indicate that the problem is enormous. Unfortunately worm infestation is generally taken lightly inspite of the fact that it has been shown to be responsible for precipitating overt malnutrition in children who are at risk. Also worms have been shown to be responsible for respiratory and allergic problems and to cause serious complications like intestinal obstruction.
Several anthelminthics are available in the market. However their spectrum of activity is limited to single worms or at most the members of the cestode group. Since laboratory facilities are generally not available and where available rather expensive, their need for a broad spectrum anthelminthic with minimal side effects which can be given safely in the absence of laboratory confirmation of worm infestation and the type of worms present, has been felt for a long time.
Our study like that of Theodonides et al,1 Georgi et al2 and Peve et al3 has shown that albendazole is a dependable broad spectrum an­thelminthic. We feel that in conditions like ours in which multiple doses cause problems of patient compliance, the introduction of a single dose effective broad spectrum anthelminthic is really welcomed. The side effects were also very minor and of short duration.


1. Theodorides, V.J., Gyrick, R.J., Kingbury, W.D. and Paris, R.C. Anthelmintic activity of albendazole against liver flukes, tapeworms, lung and gastrointestinal roundworms. Experential, 1976; 32: 702.
2. Georgi, M.E., Fahenstock, G.R. and Theodonides, V.J. Equine verminous arteritis, efficacy and speed of larvicidal activity as influenced by albendazole. Cornell Vet., 1980; 70:141.
3. Pene, P., Mojon, M., Garin, J.P., Coulaud, J.P., and Rossignol, J.F. Albendazole a new broad spectrum anthelmintic. Double-blind multicentre clinical trial. Am. J. Trop. Med. Hyg., 1982; 31: 263.
4. Farooqui, M.A. An investigation of human intes­tinal parasitism in some areas of West Pakistan. Pakistan J. Med. Res., 1964; 3:113.
5. Siddiqui, M.N. and Bano, L. Observation on parasitic infections in school children of Peshawar. PakistanJ. Zoology, 1979;2: 109.
6. Bano, L. and Yasmin, B. Observation on incidence of infection with intestinal parasites in the school children of Peshawar. Pakistan J. Med. Res., 1981; 20 (2): 49.
7. Khan, S.B. Intestinal pathogenic parasitosis in residence of Dir Town and Suburbs. Rawal Med. J., 1973;11: 19.
8. Fatima, Aly and Anzar. A survey of Intestinal protozoan Helminth parasites in Karachi. Pakistan J. Med. Res., 1982; 21(2): 54.
9. Pal, R.A. and Rana, S.I. Incidence of intestinal helminth parasites of man in the twin cities of Rawalpindi-Islamabad. JPMA., 1983; 33:33.
10. Salar Zai and Bano. Ascariasis in four refugees camps in NWFP. Pakistan J. Med. Res., 1983; 22 (2): 37.

Journal of the Pakistan Medical Association has agreed to receive and publish manuscripts in accordance with the principles of the following committees: